Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
QuintilesIMS
Baxter
Julphar
Argus Health
Johnson and Johnson
Queensland Health
Mallinckrodt
Cipla

Generated: January 17, 2019

DrugPatentWatch Database Preview

Bracco Company Profile

« Back to Dashboard

Summary for Bracco
International Patents:156
US Patents:3
Tradenames:67
Ingredients:37
NDAs:43
Patent Litigation for Bracco: See patent lawsuits for Bracco

Drugs and US Patents for Bracco

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco READI-CAT 2 SMOOTHIES barium sulfate SUSPENSION;ORAL 208143-002 Jan 15, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Bracco RENOGRAFIN-76 diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 010040-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Bracco RENOVUE-65 iodamide meglumine INJECTABLE;INJECTION 017902-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Bracco SONORX simethicone-cellulose SUSPENSION;ORAL 020773-001 Oct 29, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Bracco CARDIOGRAFIN diatrizoate meglumine INJECTABLE;INJECTION 011620-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Bracco

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco CHOLOVUE iodoxamate meglumine INJECTABLE;INJECTION 018077-001 Approved Prior to Jan 1, 1982 3,654,272 ➤ Try a Free Trial
Bracco ISOVUE-300 iopamidol INJECTABLE;INJECTION 020327-003 Oct 12, 1994 4,001,323 ➤ Try a Free Trial
Bracco PROHANCE gadoteridol INJECTABLE;INJECTION 020131-001 Nov 16, 1992 5,846,519 ➤ Try a Free Trial
Bracco CARDIOGEN-82 rubidium chloride rb-82 INJECTABLE;INJECTION 019414-001 Dec 29, 1989 4,400,358 ➤ Try a Free Trial
Bracco PROHANCE MULTIPACK gadoteridol INJECTABLE;INJECTION 021489-001 Oct 9, 2003 5,474,756 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Bracco Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2015 00014 Denmark ➤ Try a Free Trial PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150115
90018-6 Sweden ➤ Try a Free Trial PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150119
14/058 Ireland ➤ Try a Free Trial PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REGISTRATION NO/DATE: EU/1/14/924/001-002 20140516
00061 Netherlands ➤ Try a Free Trial PRODUCT NAME: ZWAVELHEXAFLUORIDE; REGISTRATION NO/DATE: EU/1/01/177/001-002 20010326
C0021 France ➤ Try a Free Trial PRODUCT NAME: PEGAPTANIB SODIUM; REGISTRATION NO/DATE: EU/1/05/325/001 20060131
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Moodys
Fuji
Fish and Richardson
Cantor Fitzgerald
Julphar
US Department of Justice
Colorcon
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.